Caidya is naming Michael Clay its new Chief Operating Officer (COO). As a global, mid-sized contract research organization (CRO), Caidya focuses on accelerating clinical development for biopharmaceutical companies. For Caidya, Clay will lead the CRO’s global operational delivery, client engagement model, and execution strategy. The company says this approach will further strengthen its ability to serve sponsors in the U.S., Europe, and Asia-Pacific. How Clay Helps Caidya Goals It is in ...